Clinical Trial

Ketamine for the Treatment of Refractory Status Epilepticus

Name: Ketamine for the Treatment of Refractory Status Epilepticus — clinical trial record (NCT07177235)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This pilot feasibility study aims to examine how the timing of ketamine introduction as a third-line anti-seizure medication infusion relates to seizure cessation in patients with refractory status epilepticus (RSE).

Trial Details

NCT Number	NCT07177235
Lead Sponsor	Thomas Jefferson University
Conditions	Refractory Status Epilepticus
Enrollment	50 participants
Start Date	2025-11
Primary Completion	2027-07 (estimated)
Study Completion	2028-07 (estimated)
Updated on ClinicalTrials.gov	2025-09-16